Previously diagnosed schizophrenia patients have lower inpatient and higher drug costs compared with newly diagnosed patients, possibly indicating better control of their disease.
Jim Lightwood, PhD
Advertisement
Articles by Jim Lightwood, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Phase 3 Trial Marks First Success for Personalized mRNA Cancer Therapy in Resected Melanoma
2
FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth
3
New Hypertension Guideline: Key Shifts for Pharmacists
4
The Main Street Pharmacy Access Act: A Small Bill Asking a Big Question
5